SCNX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Scienture Holdings Inc (SCNX) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows significant revenue growth and an impressive gross margin increase, its negative net income and declining EPS are concerning. The lack of recent news, neutral trading sentiment, and absence of proprietary trading signals further suggest that this stock does not currently present a compelling opportunity. A hold is recommended until more positive catalysts or stronger financial trends emerge.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 51.934, and moving averages are converging, suggesting no clear trend. The stock is trading below its pivot level (0.492), with key support at 0.392 and resistance at 0.592.
Gross margin improved significantly, up 1525.88% YoY.
Net income remains negative at -3,607,361, despite a slight YoY improvement. EPS dropped significantly by -85.82% YoY. No recent news or significant insider/hedge fund activity.
In Q3 2025, revenue surged by 809.71% YoY to 590,050, and gross margin increased significantly to 97.39%. However, net income remains negative at -3,607,361, and EPS dropped by -85.82% YoY, indicating profitability challenges.
Maxim initiated coverage with a Buy rating and a price target of $1.50, suggesting potential upside. However, this is a single analyst opinion with no recent updates.
